Research Topics
| Geoffrey A TargettSummaryAffiliation: London School of Hygiene and Tropical Medicine Country: UK Publications
| Collaborators
|
Detail Information
Publications
Sympatric Plasmodium falciparum isolates from Venezuela have structured var gene repertoiresAdriana Tami
Immunology Unit, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St, London, WC1E 7HT, UK
Malar J 2:7. 2003..Studies to date have compared var repertoires of natural isolates from various geographical locations but have not addressed any within-population structure that may exist among repertoires...
Efficacy of amodiaquine, sulphadoxine-pyrimethamine and their combination for the treatment of uncomplicated Plasmodium falciparum malaria in children in Cameroon at the time of policy change to artemisinin-based combination therapyWilfred F Mbacham
Biotechnology Centre, University of Yaounde I, Yaounde, Cameroon
Malar J 9:34. 2010..The prevalence of molecular markers for resistance to these drugs was studied to set the baseline for surveillance of their evolution with time...
Vaccine efficacy, and immunity affecting transmissionG Targett
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, UK
Parassitologia 41:433-6. 1999....
Artesunate reduces but does not prevent posttreatment transmission of Plasmodium falciparum to Anopheles gambiaeG Targett
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London WC1E 7HT, United Kingdom
J Infect Dis 183:1254-9. 2001..Artesunate reduced posttreatment infectivity dramatically but did not abolish it completely. The study raises questions about any policy to use pyrimethamine-sulfadoxine alone as the first-line treatment for malaria...
Malaria vaccines 1985-2005: a full circle?Geoffrey A Targett
Gates Malaria Partnership, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, 50 Bedford Square, London WC1B 3DP, UK
Trends Parasitol 21:499-503. 2005..Why is it still proving so challenging to produce effective vaccines?..
Malaria vaccines and their potential role in the elimination of malariaGeoffrey A Targett
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, London, UK
Malar J 7:S10. 2008..This might be achieved with some pre-erythrocytic stage candidate vaccines or by targeting the sexual stages directly with transmission-blocking vaccines. An expanded malaria vaccine programme with such objectives is now a priority...
Do we still need a malaria vaccine?B Greenwood
Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, Keppel St, London WC 1E 7HT, UK
Parasite Immunol 31:582-6. 2009..Malaria vaccines with transmission-blocking properties could play a key role in future elimination programmes...
Capacity strengthening in malaria research: the Gates Malaria PartnershipBrian M Greenwood
Gates Malaria Partnership, Department of Infectious and Tropical Diseases, London School of Hygiene and Tropical Medicine, 50 Bedford Square, London, WC1B 3DP, UK
Trends Parasitol 22:278-84. 2006..Capacity development, notably through a PhD programme, has been an underlying feature of all aspects of the programme...
